Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
IRVINE, Calif., Nov. 07, 2016 -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, are scheduled to participate at four investor conferences in November 2016. The first conference is the Stephens 2016 Fall Investment Conference in New York, NY.
| Event: | Stephens 2016 Fall Investment Conference | ||
| Date: | Wednesday, November 9, 2016 | ||
| Time: | 11:00 am ET / 8:00 am PT | ||
| Participant: | Vaseem Mahboob, Chief Financial Officer | ||
The second conference is the Stifel 2016 Healthcare Conference in New York, NY.
| Event: | Stifel 2016 Healthcare Conference | ||
| Date: | Tuesday, November 15, 2016 | ||
| Time: | 11:00 am ET / 8:00 am PT | ||
| Participant: | John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer | ||
The third conference is the Canaccord Genuity Medical Technologies and Diagnostics Forum in New York, NY.
| Event: | Canaccord Genuity Medical Technologies and Diagnostics Forum | ||
| Date: | Thursday, November 17, 2016 | ||
| Time: | 8:30 am ET / 5:30 am PT | ||
| Participant: | John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer | ||
The fourth conference is the 28th Annual Piper Jaffray Healthcare Conference in New York, NY.
| Event: | 28th Annual Piper Jaffray Healthcare Conference | ||
| Date: | Wednesday, November 30, 2016 | ||
| Time: | 9:30 am ET / 6:30 am PT | ||
| Participant: | Vaseem Mahboob, Chief Financial Officer | ||
An audio webcast of the Company’s presentations will be available by visiting the investor relations section of Endologix’s website at www.endologix.com. A replay of the presentations will be available for 30 days.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 80%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's website at www.endologix.com.
COMPANY CONTACT: Endologix, Inc. John McDermott, CEO Vaseem Mahboob, CFO (949) 595-7200 www.endologix.com INVESTOR CONTACTS: The Ruth Group Nick Laudico (646) 536-7030 Zack Kubow (646) 536-7020
